SeLux Diagnostics
PrivateLast Round
Series C
Extension
Apr 1, 2024
Total Funding Raised
$268.25M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SeLux Diagnostics is a biotechnology company that develops a rapid phenotyping platform for antibiotic susceptibility testing and the diagnosis of infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SeLux Diagnostics Comparables
Compare SeLux Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PhAST Diagnostics | 89% | |
| First Light Diagnostics, Inc. | 88% | |
| Pattern Bioscience | 88% |
SeLux Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Apr 1, 2024 | ||||
| Series C Extension | Feb 13, 2024 | ||||
| Grant | Jul 12, 2022 | ||||
| Debt | Jun 1, 2022 | ||||
| Series C | Feb 28, 2022 | ||||
Grant | Oct 19, 2021 |
Key People
Founding team and executive leadership
SeLux Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B, Series C, Series C Extension |
| NIH RADx | Grant |
| Northpond Ventures | Series C, Series B, Series C Extension |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| Schooner Capital | Series C, Series B, Series C Extension |
| Biomedical Advanced Research and Development Authority | Grant |
| Oxford Finance | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 5532% MoM, from 41 to 2.3K.
- Apr 1, 2024
$48M round led by RA Capital Management.
SeLux Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SeLux Diagnostics's valuation, stock price, and market status.
Is SeLux Diagnostics a public or private company?
SeLux Diagnostics is a private company.
What is the current stock price of SeLux Diagnostics?
SeLux Diagnostics is a private company with no public stock price. No recent secondary market data is available.
How much is SeLux Diagnostics worth (valuation)?
Valuation information for SeLux Diagnostics is not publicly available.
Can I buy SeLux Diagnostics stock?
SeLux Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SeLux Diagnostics's last funding round?
SeLux Diagnostics's most recent funding round was Series C Extension on April 1, 2024.
Who are the main investors in SeLux Diagnostics?
Key investors in SeLux Diagnostics include RA Capital Management, Oxford Finance, Sands Capital.
Will SeLux Diagnostics IPO soon?
No public IPO plans have been announced for SeLux Diagnostics.
How can I track SeLux Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SeLux Diagnostics's secondary market activity and sign up for updates.